GSK PLC (GSK)
39.28
-0.32
(-0.81%)
USD |
NYSE |
Apr 18, 16:00
39.28
0.00 (0.00%)
After-Hours: 20:00
GSK Price: 39.28 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 17, 2024 | 39.72 | 39.85 | 39.44 | 39.60 | 2.766M |
| Apr 16, 2024 | 40.02 | 40.23 | 39.72 | 39.95 | 2.423M |
| Apr 15, 2024 | 40.90 | 41.06 | 40.44 | 40.50 | 3.374M |
| Apr 12, 2024 | 40.96 | 40.97 | 40.49 | 40.66 | 5.265M |
| Apr 11, 2024 | 41.00 | 41.25 | 40.68 | 40.80 | 2.904M |
| Apr 10, 2024 | 40.62 | 40.75 | 40.48 | 40.69 | 4.370M |
| Apr 09, 2024 | 40.89 | 40.96 | 40.67 | 40.88 | 3.191M |
| Apr 08, 2024 | 41.08 | 41.08 | 40.82 | 40.85 | 1.856M |
| Apr 05, 2024 | 40.59 | 41.25 | 40.54 | 41.19 | 6.093M |
| Apr 04, 2024 | 41.73 | 41.88 | 40.84 | 40.86 | 2.634M |
| Apr 03, 2024 | 41.50 | 41.74 | 41.32 | 41.54 | 3.049M |
| Apr 02, 2024 | 42.13 | 42.14 | 41.67 | 41.79 | 2.582M |
| Apr 01, 2024 | 42.74 | 42.87 | 42.22 | 42.42 | 1.515M |
| Mar 28, 2024 | 43.00 | 43.22 | 42.86 | 42.87 | 1.855M |
| Mar 27, 2024 | 42.58 | 43.03 | 42.51 | 42.99 | 2.077M |
| Mar 26, 2024 | 42.83 | 42.89 | 42.55 | 42.79 | 3.042M |
| Mar 25, 2024 | 42.58 | 43.45 | 42.56 | 42.83 | 3.437M |
| Mar 22, 2024 | 42.54 | 42.68 | 42.33 | 42.35 | 1.483M |
| Mar 21, 2024 | 42.17 | 42.54 | 42.15 | 42.37 | 2.024M |
| Mar 20, 2024 | 42.02 | 42.04 | 41.75 | 41.93 | 1.799M |
| Mar 19, 2024 | 42.24 | 42.33 | 42.07 | 42.32 | 1.999M |
| Mar 18, 2024 | 42.21 | 42.35 | 42.14 | 42.14 | 1.346M |
| Mar 15, 2024 | 42.28 | 42.43 | 41.81 | 42.19 | 4.130M |
| Mar 14, 2024 | 43.21 | 43.26 | 42.81 | 43.08 | 1.843M |
| Mar 13, 2024 | 43.27 | 43.37 | 43.08 | 43.36 | 1.678M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
28.66
Minimum
Sep 27 2022
58.56
Maximum
Apr 13 2022
40.80
Average
40.18
Median
Price Benchmarks
| AstraZeneca PLC | 68.36 |
| Haleon PLC | 8.13 |
| Novo Nordisk A/S | 122.75 |
| Pfizer Inc | 25.38 |
| Sanofi SA | 45.40 |
Price Related Metrics
| PE Ratio | 14.05 |
| PS Ratio | 2.268 |
| Price to Book Value | 4.720 |
| Price to Free Cash Flow | 15.55 |
| Earnings Yield | 7.12% |
| Market Cap | 80.25B |
| Operating PE Ratio | 9.370 |
| Normalized PE Ratio | 12.84 |